Skip to Content

The ANRESIS-guide

The ANRESIS-guide aims at assisting health professionals by providing intuitive access to the latest antimicrobial resistance data and swiss national guidelines.

Learn more

Antibiotic Resistance

Antibiotic resistance is worldwide on the rise. It is one of the most important threats for human medicine in this century.

Learn more

Antibiotic Consumption

Antibiotic use is one of the most important triggers for antibiotic resistance.

Learn more

Resistance Data Veterinary Medicine

Antibiotic resistance affects human and veterinary medicine (“one health”).

Learn more

ANRESIS, the Swiss Centre for Antibiotic Resistance is a nationwide, representative surveillance system and research instrument for antibiotic resistance and consumption. It is led by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.

In a programme on Swiss radio SRF it was discussed why we should pay attention to global AMR trends and the situation in animals. With insights from ANRESIS. Tune in now! https://www.anresis.ch/wp-content/uploads/2024/10/wissenschaftsmagazin_AMR_kurz.mp3
(German, SRF Wissenschaftsmagazin 28.9.24)

Antibiotic use also matters for C. difficile incidence rates. Learn more from the ANRESIS poster at the Joint Annual Meeting of SSI/SSM/SSHH 2024 in Bern. https://www.anresis.ch/wp-content/uploads/2024/08/CDIFF_poster_SSHH-Symp_Wassilew.pdf

📰Read our latest study on how the COVID-19 pandemic affected ESCR E. coli and K. pneumoniae bloodstream infections in Switzerland.
https://www.anresis.ch/wp-content/uploads/2024/07/2024_covid_amr_j_hosp_inf.pdf

Load more ANRESIS tweets

ANRESIS continuously collects all anonymized resistance data that is generated in routine diagnostics from

> 35 Laboratories for human medicine
10 Laboratories for veterinary medicine
> 70 Hospital pharmacies
> 1000 Pharmacies

ANRESIS is supported by the following Organisations

Back to top